Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition

References

• Adrain C, Freeman M. (2012). New lives for old: Evolution of psuedoenzyme function illustrated by iRhoms. Nat Rev Mol Cell Biol 13:489–498
   PubMed Web of Science ®Google Scholar
• Anand BS, Mitra AK. (2002). Mechanism of corneal permeation of L-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea. Pharm Res 19:1194–1202
   PubMed Web of Science ®Google Scholar
• Anand BS, Katragadda S, Mitra AK. (2004). Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: Intestinal absorption and liver metabolism. J Pharmacol Exp Ther 311:659–667
   PubMed Web of Science ®Google Scholar
• Anderson RE. (1970). Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. Exp Eye Res 10:339–344
   PubMed Web of Science ®Google Scholar
• Baer BR, Rettie AE. (2006). CYP4B1: An enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab Rev 38:451–476
   PubMed Web of Science ®Google Scholar
• Baragatti B, Schwartzman ML, Angeloni D, et al. (2009). EDHF function in the ductus arteriosus: Evidence against involvement of epoxyeicosatrienoic acids and 12S-hydroxyeicosatetraenoic acid. Am J Physiol Heart Circ Physiol 297:H2161–H2168
   PubMed Web of Science ®Google Scholar
• Barot M, Gokulgandhi MR, Pal D, Mitra AK. (2013). Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells – Nocel stratefies for intracellular drug targeting. Exp Eye Res 106:47–54
   PubMed Web of Science ®Google Scholar
• Bar-Yosef U, Levy J, Elbedour K, et al. (2010). Congenital glaucoma: CYP1B1 mutations in Israeli Bedouin kindreds. J Glaucoma 19:35–38
   PubMed Web of Science ®Google Scholar
• Bayat B, Yazdani S, Alavi A, et al. (2008). Contributions of MYOC and CYP1B1 mutations to JOAG. Mol Vis 13:508–517
   Google Scholar
• Bazan NG, Calandria JM, Serhan CN. (2010). Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J Lipid Res 51:2018–2031
   PubMed Web of Science ®Google Scholar
• Bejjani BA, Xu L, Armstrong D, et al. (2002). Expression patterns of cytochrome P4501B1 (Cyp1b1) in FVB/N mouse eyes. Exp Eye Res 75:249–257
   PubMed Web of Science ®Google Scholar
• Beuten J, Gelfond JA, Byrne JJ, et al. (2008). CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis 29:1751–1757
   PubMed Web of Science ®Google Scholar
• Bietti G. (1937). Ueber familiaeres vorkommen von“retinitis punctata albescens” (verbunden mit”dystrophia marginalis cristallinea cormeae”), glitzern des glaskoerpers und anderen degenerativen augenveraenderungen. Klin Mbl Augenheilk 99:737–757
   Google Scholar
• Bogni A, Monshouwer M, Moscone A, et al. (2005). Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles. Toxicol In Vitro 19:621–629
   PubMed Web of Science ®Google Scholar
• Bonazzi A, Mastyugin V, Mieyal PA, et al. (2000). Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J Biol Chem 275:2837–2844
   PubMed Web of Science ®Google Scholar
• Bras AP, Sitar DS, Aoki FY. (2001). Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol 8:207–211
   PubMedGoogle Scholar
• Campbell M, Humphries P. (2012). The blood-retina barrier: Tight juctions and barrier modulation. Adv Exp Med Biol 763:70–84
   PubMed Web of Science ®Google Scholar
• Capdevila J, Yadagiri P, Manna S, Falck JR. (1986). Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. Biochem Biophys Res Commun 141:1007–1011
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Ghanekar Y, Kaur K, et al. (2010). A polymorphism in the CYP1B1 promoter is functionally associated with primary congenital glaucoma. Hum Mol Genet 19:4083–4090
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S, Kaur K, Kaur I, et al. (2006). Globally, CYP1B1 mutations in primary congenital glaucoma are strongly structured by geographic and haplotype backgrounds. Invest Ophthalmol Vis Sci 47:43–47
   PubMed Web of Science ®Google Scholar
• Chambers D, Wilson L, Maden M, Lumsden A. (2007). RALDH-independent generation of retinoic acid during vertebrate embryogenesis by CYP1B1. Development 134:1369–1383
   PubMed Web of Science ®Google Scholar
• Chavarria-Soley G, Sticht H, Aklillu E, et al. (2008). Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme. Hum Mutat 29:1147–1153
   PubMed Web of Science ®Google Scholar
• Chen P, Chen H, Zang X, et al. (2013). Expression of efflux transporters in human ovular tissues. Drug Metab Dispos 42:1934–1948
   Google Scholar
• Choudhary D, Jansson I, Stoilov I, et al. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32:840–847
   PubMed Web of Science ®Google Scholar
• Choudhary D, Jansson I, Sarfarazi M, Schenkman JB. (2008). Characterization of the biochemical and structural phenotypes of four CYP1B1 mutations observed in individuals with primary congenital glaucoma. Pharmacogenet Genomics 18:665–676
   PubMed Web of Science ®Google Scholar
• Congdon N, O'colmain B, Klaver CC, et al. (2004). Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477–485
   PubMed Web of Science ®Google Scholar
• Conners MS, Stoltz RA, Davis KL, et al. (1995a). A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest Ophthalmol Vis Sci 36:841–850
   PubMed Web of Science ®Google Scholar
• Conners MS, Stoltz RA, Webb SC, et al. (1995b). A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome P450 arachidonic acid metabolites. Invest Ophthalmol Vis Sci 36:828–840
   PubMed Web of Science ®Google Scholar
• Dahlin A, Geier E, Stocker SL, et al. (2013). Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm 10:650–663
   PubMedGoogle Scholar
• Dey S, Patel J, Anand BS, et al. (2003). Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci 44:2909–2918
   PubMed Web of Science ®Google Scholar
• Dias C, Nashed Y, Atluri H, Mitra A. (2002). Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS. Curr Eye Res 25:243–252
   PubMed Web of Science ®Google Scholar
• Divi RL, Luch A, Verma M, Mahadevan B. (2012). CYP1B1 detection. Curr Protoc Toxicol 51:4.31.1–4.31.26
   Google Scholar
• Doshi M, Marcus C, Bejjani BA, Edward DP. (2006). Immunolocalization of CYP1B1 in normal, human, fetal and adult eyes. Exp Eye Res 82:24–32
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, Domb AJ. (2005). Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel. J Control Release 106:386–390
   PubMed Web of Science ®Google Scholar
• Esilae R. (1963). Histochemical and electrophoretic properties of cholinesterases and non-specific esterases in the retina of some mammals, including man. Acta Ophthalmol Suppl 77:1–113
   Google Scholar
• Esilae R. (1964). Histochemistry of retinal esterases. Acta Ophthalmol (Copenh) 42:435–437
   PubMed Web of Science ®Google Scholar
• Fer M, Corcos L, Dreano Y, et al. (2008). Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism. J Lipid Res 49:2379–2389
   PubMed Web of Science ®Google Scholar
• Fisher MB, Zheng YM, Rettie AE. (1998). Positional specificity of rabbit CYP4B1 for omega-hydroxylation1 of short-medium chain fatty acids and hydrocarbons. Biochem Biophys Res Commun 248:352–355
   PubMed Web of Science ®Google Scholar
• Fliesler S, Anderson RE. (1983). Chemistry and metabolism of lipids in the vertebrate. Prog Lipid Res 22:79–131
   PubMed Web of Science ®Google Scholar
• Fuse N, Miyazawa A, Takahashi K, et al. (2010). Mutation spectrum of the CYP1B1 gene for congenital glaucoma in the Japanese population. Jpn J Ophthalmol 54:1–6
   PubMed Web of Science ®Google Scholar
• Gajjar K, Martin-Hirsch PL, Martin FL. (2012). CYP1B1 and hormone-induced cancer. Cancer Lett 324:13–30
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia GP, Lopez-Garrido MP, Martinez-Rubio M, et al. (2013). Genotype-phynotype analysis of Bietti crystalline dystrophy in a family with the CYP4V2 Ile111Thr mutation. Cornea 32:1002–1008
   PubMed Web of Science ®Google Scholar
• Gekka T, Hayashi T, Takeuchi T, et al. (2005). CYP4V2 mutations in two Japanese patients with Bietti's crystalline dystrophy. Ophthalmic Res 37:262–269
   PubMed Web of Science ®Google Scholar
• Gordon WC, Bazan NG. (1993). Visualization of [3H]docosahexaenoic acid trafficking through photoreceptors and retinal pigment epithelium by electron microscopic autoradiography. Invest Ophthalmol Vis Sci 34:2402–2411
   PubMed Web of Science ®Google Scholar
• Grauer SM, Pulito VL, Navarra RL, et al. (2009). Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. J Pharmacol Exp Ther 331:574–590
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2005). Human cytochrome P450 enzymes. In: Ortiz De Montellano PR, ed. Cytochrome P450 structure, mechanism, and biochemistry. 3rd ed. New York: Kluwer Academic/Plenum Publisher, 377–530
   Google Scholar
• Guisto NM, Pasquare SJ, Salvador GA, et al. (2000). Lipid metabolism in vertebrate retinal rod outer segments. Prog Lipid Res 39:315–391
   PubMed Web of Science ®Google Scholar
• Haddad NM, Waked N, Bejjani R, et al. (2012). Clinical and molecular finding s in three Lebanese families with Bietti crystalline dystrophy: Report on a noval mutation. Mol Vis 18:1182–1188
   PubMed Web of Science ®Google Scholar
• Han CL, Liao CS, Wu CW, et al. (1998). Contribution to first-pass metabolism of ethanol and inhibition by ethanol for retinol oxidation in human alcohol dehydrogenase family – Implications for etiology of fetal alcohol syndrome and alcohol-related diseases. Eur J Biochem 254:25–31
   PubMedGoogle Scholar
• Han EH, Kim HG, Hwang YP, et al. (2010). Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells. Toxicol Sci 114:204–216
   PubMed Web of Science ®Google Scholar
• Hardwick JP. (2008). Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 75:2263–2275
   PubMed Web of Science ®Google Scholar
• Hilal L, Boutayeb S, Serrou A, et al. (2010). Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: Three novel mutations in CYP1B1. Mol Vis 16:1215–1226
   PubMed Web of Science ®Google Scholar
• Hosoya KI, Tomi M. (2005). Advances in the cell biology of transport via the inner blood-retinal barrier: Establishment of cell lines and transport functions. Biol Pharm Bull 28:1–8
   PubMed Web of Science ®Google Scholar
• Hosoya KI, Tachikawa M. (2009). Inner blood-retinal barrier transporters: Role of retinal drug delivery. Pharm Res 26:2055–2065
   PubMed Web of Science ®Google Scholar
• Hsu MH, Savas U, Griffin KJ, Johnson EF. (2007). Human cytochrome p450 family 4 enzymes: Function, genetic variation and regulation. Drug Metab Rev 39:515–538
   PubMed Web of Science ®Google Scholar
• Huang HS, Schoenwald RD, Lach JL. (1983). Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions. J Pharm Sci 72:1272–1279
   PubMed Web of Science ®Google Scholar
• Hulsman CA, Westendorp IC, Ramrattan RS, et al. (2001). Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemol 154:138–144
   PubMed Web of Science ®Google Scholar
• Hutchins JB. (1987). Acetylcholine as a neurotransmitter in the vertebrate retina. Exp Eye Res 45:1–38
   PubMed Web of Science ®Google Scholar
• Hutchins JB, Hollyfield JG. (1987). Acetylcholinesterase in the human retina. Brain Res 400:300–311
   PubMed Web of Science ®Google Scholar
• Jain-Vakkalagadda B, Dey S, Pal D, Mitra AK. (2003). Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea. Invest Ophthalmol Vis Sci 44:2919–2927
   PubMed Web of Science ®Google Scholar
• Jain-Vakkalagadda B, Pal D, Gunda S, et al. (2004). Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm 1:338–346
   PubMed Web of Science ®Google Scholar
• Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. (2001). Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. Pharmacogenetics 11:793–801
   PubMedGoogle Scholar
• Jin ZB, Ito S, Saito Y, et al. (2006). Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn J Ophthalmol 50:426–431
   PubMed Web of Science ®Google Scholar
• Kaiser-Kupfer MI, Chan CC, Markello TC, et al. (1994). Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol 118:569–582
   PubMed Web of Science ®Google Scholar
• Karla PK, Pal D, Mitra AK. (2007a). Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells. Exp Eye Res 84:53–60
   PubMed Web of Science ®Google Scholar
• Karla PK, Pal D, Quinn T, Mitra AK. (2007b). Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. Int J Pharm 336:12–21
   PubMed Web of Science ®Google Scholar
• Karypidis AH, Soderstrom T, Nordmark A, et al. (2006). Association of cytochrome P450 1B1 polymorphism with first-trimester miscarriage. Fertil Steril 86:1498–1503
   PubMed Web of Science ®Google Scholar
• Katragadda S, Gunda S, Hariharan S, Mitra AK. (2008). Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: Evaluation of their utility in treating ocular HSV infections. Int J Pharm 359:15–24
   PubMed Web of Science ®Google Scholar
• Kelly EJ, Nakano M, Rohatgi P, et al. (2011). Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Mol Interv 11:124–132
   PubMed Web of Science ®Google Scholar
• Kim I, Chu XY, Kim S, et al. (2003). Identification of a human valacyclovirase: Biphenyl hydrolase-like protein as valacyclovir hydrolase. J Biol Chem 278:25348–25356
   PubMed Web of Science ®Google Scholar
• Kim JH, Sherman ME, Curriero FC, et al. (2004). Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol Appl Pharmacol 199:210–219
   PubMed Web of Science ®Google Scholar
• Kingman S. (2004). In focus: Glaucoma is second leading cause of blindness globally. Bull World Health Organ 82:887–888
   PubMed Web of Science ®Google Scholar
• Lai TY, Chu KO, Chan KP, et al. (2010). Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci 51:1092–1097
   PubMed Web of Science ®Google Scholar
• Lam KW, Feman SS, Ray GS, Van Heuven WA. (1977). A biochemical characterization of the carboxyl esterases in human subretinal fluid – A study comparing the enzymes in serum, in leukocytes, and in subretinal fluid. Exp Eye Res 24:467–477
   PubMed Web of Science ®Google Scholar
• Lee J, Jiao X, Hejtmancik JF, et al. (2001). The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci 42:1707–1714
   PubMed Web of Science ®Google Scholar
• Lee KY, Koh AH, Aung T, et al. (2005). Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci 46:3812–3816
   PubMed Web of Science ®Google Scholar
• Lee VH. (1983). Esterase activities in adult rabbit eyes. J Pharm Sci 72:239–244
   PubMed Web of Science ®Google Scholar
• Lee VH, Iimoto DS, Takemoto KA. (1982a). Subcellular distribution of esterases in the bovine eye. Curr Eye Res 2:869–876
   PubMed Web of Science ®Google Scholar
• Lee VH, Morimoto KW, Stratford RE Jr. (1982b). Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability. Biopharm Drug Dispos 3:291–300
   PubMed Web of Science ®Google Scholar
• Li A, Jiao X, Munier FL, et al. (2004). Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 74:817–826
   PubMed Web of Science ®Google Scholar
• Li N, Zhou Y, Du L, et al. (2011). Overview of cytochrome P450 1B1 gene mutations in patients with primary congenitalglaucoma. Exp Eye Res 93:572–579
   PubMed Web of Science ®Google Scholar
• Libby RT, Smith RS, Savinova OV, et al. (2003). Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299:1578–1581
   PubMed Web of Science ®Google Scholar
• Lin J, Nishiguchi KM, Nakamura M, et al. (2005). Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. J Med Genet [online] Available from: http://jmg.bmj.com/content/42/6/e38.long [last accessed 16 May 2014]
   Google Scholar
• Loannides C, Lewis DF. (2004). Cytochrome P450 in the bioactivation of chemicals. Curr Top Med Chem 4:1767–1788
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Krausz KW, Gonzalez FJ. (2005). Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos 33:489–494
   PubMed Web of Science ®Google Scholar
• Macha S, Mitra AK, Hughes PH. (1993). Ophthalmic drug delivery systems. New York: Marcel Dekker
   Google Scholar
• Mamatha G, Umashankar V, Kasinathan N, et al. (2011). Moleculat screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization. Mol Vis 17:1970–1977
   PubMed Web of Science ®Google Scholar
• Mannermaa E, Vellonen KS, Urtti A. (2006). Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–1163
   PubMed Web of Science ®Google Scholar
• Manzouri B, Sergouniotis PI, Robson AG, et al. (2012). Bietti crystalline retinopathy: Report of retinal crystal deposition in make adolescent siblings. Arch Ophthalmol 130:1470–1473
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Rios AP, Schwartzman ML. (1990). Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid. Biochem Pharmacol 39:1971–1974
   PubMed Web of Science ®Google Scholar
• Mastyugin V, Aversa E, Bonazzi A, et al. (1999). Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: Involvement of a cytochrome P-4504B1 isoform. J Pharmacol Exp Ther 289:1611–1619
   PubMed Web of Science ®Google Scholar
• Mastyugin V, Mosaed S, Bonazzi A, et al. (2001). Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear. Curr Eye Res 23:1–10
   PubMed Web of Science ®Google Scholar
• Mastyugin V, Mezentsev A, Zhang WX, et al. (2004). Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia. J Cell Biochem 91:1218–1238
   PubMed Web of Science ®Google Scholar
• Meyer CH, Rodrigues EB, Mennel S, Schmidt JC. (2004). Optical coherence tomography in a case of Bietti's crystalline dystrophy. Acta Ophthalmol Scand 82:609–612
   PubMedGoogle Scholar
• Mezentsev A, Mastyugin V, Seta F, et al. (2005). Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels. J Pharmacol Exp Ther 315:42–50
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Modarati G, Galli L, Rama P. (2007). Efficacy of valavyvlovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: A pilot stydy. Am J Ophthalmol 144:547–551
   PubMed Web of Science ®Google Scholar
• Miyata N, Taniguchi K, Seki T, et al. (2001). HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 133:325–329
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. (2004). Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101:8491–8496
   PubMed Web of Science ®Google Scholar
• Murray GI, Patimalla S, Stewart KN, et al. (2010). Profiling the expression of cytochrome P450 in breast cancer. Histopathology 57:202–211
   PubMed Web of Science ®Google Scholar
• Nakamura M, Lin J, Nishiguchi K, et al. (2006). Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations. Adv Exp Med Biol 572:49–53
   PubMed Web of Science ®Google Scholar
• Nakano MJ, Kelly EJ, Wiek C, et al. (2012). CYP4V2 in Bietti’s crystalline dystrophy: Ocular localization, metabolism of ω3 polyunsaturated fatty acids and functional deficit of the H331P variant. Mol Pharmacol 82:679–686
   PubMed Web of Science ®Google Scholar
• Nakano M, Kelly EJ, Rettie AE. (2009). Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metab Dispos 37:2119–2122
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, et al. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature alternative-splice variants. Pharmacogenetics 14:1–18
   PubMedGoogle Scholar
• Nishimura M, Schwartzman ML, Falck JR, et al. (1991). Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: Formation of novel metabolites. Arch Biochem Biophys 290:326–335
   PubMed Web of Science ®Google Scholar
• Nishizawa C, Wang JY, Sekine S, Saito M. (2003). Effect of dietary DHA on DHA levels in retinal rod outer segments in young versus mature rats. Int J Vitam Nutr Res 73:259–265
   PubMed Web of Science ®Google Scholar
• Paik J, Haenisch M, Muller CH, et al. (2014). Inhibition of retinoic acid biosynthesis by WIN 18,466 markedly suppresses spermatogenesis and alters retinoid metabolism in mice. J Biol Chem [online] Available from: http://www.jbc.org/content/early/2014/04/07/jbc.M113.540211.long [last accessed 16 May 2014]
   Google Scholar
• Parkinson OT, Liggitt HD, Rettie AE, Kelly EJ. (2013). Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol. Toxicol Sci 134:243–250
   PubMed Web of Science ®Google Scholar
• Pasutto F, Chavarria-Soley G, Mardin CY, et al. (2010). Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1. Science 299:1578–1581
   Google Scholar
• Prasad B, Evers R, Gupta A, et al. (2014). Interindividual variability in hepatic organic anion-transporting polypeptides and p-glycoprotein (ABCB1) protein expression: Quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex. Drug Metab Dispos 42:78–88
   PubMed Web of Science ®Google Scholar
• Prokudin I, Simons C, Grigg JR, et al. (2013). Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1. Eur J Hum Genet [online] Available from: http://www.nature.com/ejhg/journal/vaop/ncurrent/pdf/ejhg2013268a.pdf [last accessed 16 May 2014]
   Google Scholar
• Rettie AE, Kelly EJ. (2008). The CYP4 family. In: Ioannides C, ed. Cytochome P450: Role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge, UK: Royal Society of Chemistry, 385–407
   Google Scholar
• Ross D, Cohen AI, Mcdougal DB Jr. (1975). Choline acetyltransferase and acetylcholine esterase activities in normal and biologically fractionated mouse retinas. Invest Ophthalmol 14:756–761
   PubMedGoogle Scholar
• Rossi S, Testa F, Li A, et al. (2011). An atypicla form of Bietti crystalline dystrophy. Ophthalmic genet 32:118–121
   PubMed Web of Science ®Google Scholar
• Rossi S, Testa F, Li A, et al. (2013). Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br J Ophthalmol 97:174–179
   PubMed Web of Science ®Google Scholar
• Sarfarazi M, Akarsu AN, Hossain A, et al. (1995). Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 30:171–177
   PubMed Web of Science ®Google Scholar
• Sarraf D, Ceron O, Rasheed K, et al. (2003). West African crystalline maculopathy. Arch Ophthalmol 121:338–342
   PubMed Web of Science ®Google Scholar
• Sato M, Ishii T, Kobayashi-Matsunaga Y, et al. (2001). Discovery of a N′-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett 11:2993–2995
   PubMed Web of Science ®Google Scholar
• Schultz C, Breaux J, Schentag J, Morck D. (2011). Drug delivery to the posterior segment of the eye through hydrogel contact lenses. Clin Exp Optom 94:212–218
   PubMed Web of Science ®Google Scholar
• Scott BL, Bazan NG. (1989). Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 86:2903–2907
   PubMed Web of Science ®Google Scholar
• Seki T, Wang MH, Miyata N, Laniado-Schwartzman M. (2005). Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis. Biol Pharm Bull 28:1651–1654
   PubMed Web of Science ®Google Scholar
• Serhan CN, Arita M, Hong S, Gotlinger K. (2004). Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39:1125–1132
   PubMed Web of Science ®Google Scholar
• Seta F, Patil K, Bellner L, et al. (2007). Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins Other Lipid Mediat 84:116–127
   PubMed Web of Science ®Google Scholar
• Shan M, Dong B, Zhao X, et al. (2005). Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy. Mol Vis 11:738–743
   PubMed Web of Science ®Google Scholar
• Shichi H, Nebert DW. (1982). Genetic differences in drug metabolism associated with ocular toxicity. Environ Health Perspect 44:107–117
   PubMed Web of Science ®Google Scholar
• Shimada T, Hayes CL, Yamazaki H, et al. (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979–2984
   PubMed Web of Science ®Google Scholar
• Smith SM, Uslaner JM, Cox CD, et al. (2013). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology 64:215–223
   PubMed Web of Science ®Google Scholar
• Song Y, Mo G, Yin G. (2013). A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy. Int Ophthalmol 33:269–276
   PubMedGoogle Scholar
• Stark K, Guengerich FP. (2007). Characterization of orphan human cytochromes P450. Drug Metab Rev 39:627–637
   PubMed Web of Science ®Google Scholar
• Stiemke MM, Edelhauser HF, Geroski DH. (1991). The developing corneal endothelium: Correlation of morphology, hydration and Na/K ATPase pump site density. Curr Eye Res 10:145–156
   PubMed Web of Science ®Google Scholar
• Stoilov I, Akarsu AN, Alozie I, et al. (1998). Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 62:573–584
   PubMed Web of Science ®Google Scholar
• Stoilov I, Akarsu AN, Sarfarazi M. (1997). Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6:641–647
   PubMed Web of Science ®Google Scholar
• Stoltz RA, Conners MS, Dunn MW, Schwartzman ML. (1994). Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: Evidence for cytochrome P450-mediated reactions. J Ocul Pharmacol 10:307–317
   PubMedGoogle Scholar
• Su CC, Liu YF, Li SY, et al. (2012). Mutations in the CYP1B1 gene may contribute to juvenile-onset open-angle glaucoma. Eye (Lond) 26:1369–1377
   PubMed Web of Science ®Google Scholar
• Suri F, Yazdani S, Narooie-Nejhad M, et al. (2009). Variable expressivity and high penetrance of CYP1B1 mutations associated with primary congenital glaucoma. Ophthalmology 116:2101–2109
   PubMed Web of Science ®Google Scholar
• Thrimawithana TR, Young S, Bunt CR, et al. (2011). Drug delivery to the posterior segment of the eye. Drug Discov Today 16:270–277
   PubMed Web of Science ®Google Scholar
• Turner KR, McFarland W, Kellogg TA, et al. (2003). Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis 30:331–334
   PubMed Web of Science ®Google Scholar
• Usui T, Tanimoto N, Takagi M, et al. (2001). Rod and cone a-waves in three cases of Bietti crystalline chorioretinal dystrophy. Am J Ophthalmol 13:2395–2402
   Google Scholar
• Vafeas C, Mieyal PA, Urbano F, et al. (1998). Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium. J Pharmacol Exp Ther 287:903–910
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Gonzalez FJ. (2008). Role of CYP1B1 in glaucoma. Annu Rev Pharmacol Toxicol 48:333–358
   PubMed Web of Science ®Google Scholar
• Ventrice P, Leporini C, Aloe JF, et al. (2013). Anti-vascular endothelial growth factor drugs safety and efficacy in opthalmic diseases. J Pharmacol Pharmacother Suppl 1:S38–S42
   Google Scholar
• Vincent AL, Billingsley G, Buys Y, et al. (2002). Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 70:448–460
   PubMed Web of Science ®Google Scholar
• Vincent A, Billingsley G, Priston M, et al. (2006). Further support of the role of CYP1B1 in patients with Peters anomaly. Mol Vis 12:506–510
   PubMed Web of Science ®Google Scholar
• Wada Y, Itabashi T, Sato H, et al. (2005). Screening for mutations in CYP4V2 gene in Japanese patients with Bietti's crystalline corneoretinal dystrophy. Am J Ophthalmol 139:894–849
   PubMed Web of Science ®Google Scholar
• Wang A, Savas U, Stout CD, Johnson EF. (2011). Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286:5736–5743
   PubMed Web of Science ®Google Scholar
• Wang Y, Guo L, Cai SP, et al. (2012). Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa. PLoS One 7:e33673
   PubMed Web of Science ®Google Scholar
• Welch RB. (1977). Bietti's tapetoretinal degeneration with marginal corneal dystrophy crystalline retinopathy. Trans Am Ophthalmol Soc 75:164–197
   PubMedGoogle Scholar
• Wilson DJ, Weleber RG, Klein ML, et al. (1989). Bietti's crystalline dystrophy: A clinicopathologic correlative study. Arch Ophthalmol 107:213–221
   PubMed Web of Science ®Google Scholar
• Woollard PM. (1986). Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem Biophys Res Commun 136:169–176
   PubMed Web of Science ®Google Scholar
• Xiao X, Mai G, Li S, et al. (2011). Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. Biochem Biophys Res Commun 409:181–186
   PubMed Web of Science ®Google Scholar
• Xinming L, Yingde C, Lloyd AW, et al. (2008). Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: A review. Cont Lens Anterior Eye 31:57–64
   PubMedGoogle Scholar
• Yamamoto S, Nishimura M, Conners MS, et al. (1994). Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomes. Biochim Biophys Acta 1210:217–225
   PubMed Web of Science ®Google Scholar
• Yokoi Y, Nakazawa M, Mizukoshi S, et al. (2010). Crystal deposits on the lens capsules in Bietti crystalline corneoretinal dystrophy associated with a mutation in the CYP4V2 gene. Acta Ophthalmol 88:607–609
   Google Scholar
• Yokoi Y, Sato K, Aoyagi H, et al. (2011). A novel compound heterozygous mutation in the CYP4V2 gene in a Japanese patient with Bietti's crystalline corneoretinal dystrophy. Case Rep Ophthalmol 2:296–301
   Google Scholar
• Young RW. (1967). The renewal of photoreceptor cell outer segments. J Cell Biol 33:61–72
   PubMed Web of Science ®Google Scholar
• Young RW. (1971). Shedding of discs from rod outer segments in the rhesus monkey. J Ultrastruct Res 34:190–203
   Google Scholar
• Young RW. (1976). Visual cells and the concept of renewal. Invest Ophthalmol Vis Sci 15:700–725
   PubMed Web of Science ®Google Scholar
• Zenteno JC, Ayala-Ramirez R, Graue-Wiechers F. (2008). Novel CYP4V2 gene mutation in a Mexican patient with Bietti's crystalline corneoretinal dystrophy. Curr Eye Res 33:313–318
   PubMed Web of Science ®Google Scholar
• Zhang T, Xiang CD, Gale D, et al. (2008). Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: Implications for ocular drug disposition. Drug Metab Dispos 36:1300–1307
   PubMed Web of Science ®Google Scholar
• Zheng YM, Fisher MB, Yokotani N, et al. (1998). Identification of a meander region proline residue critical for heme binding to cytochrome P450: Implications for the catalytic function of human CYP4B1. Biochemistry 37:12847–12851
   PubMed Web of Science ®Google Scholar
• Zheng YM, Henne KR, Charmley P, et al. (2003). Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis. Toxicol Appl Pharmacol 186:119–126
   PubMed Web of Science ®Google Scholar